ஓடை வாழ்க்கை அறிவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from ஓடை வாழ்க்கை அறிவியல் நிறுவனம். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In ஓடை வாழ்க்கை அறிவியல் நிறுவனம் Today - Breaking & Trending Today

Brooks Life Sciences and GENEWIZ to host 2-day virtual event focused on cell and gene therapy April 7-8, 2021


Share this article
SOUTH PLAINFIELD, N.J., April 6, 2021 /PRNewswire/ The
Advancing CGT Virtual Event presented by GENEWIZ and Brooks Life Sciences, opens on April 7-8, 2021 and aims to discuss the opportunities, challenges, and latest technology breakthroughs in cell and gene therapy. This free, 2-day meeting offers a platform for industry leaders and researchers from across the globe to present some of the latest research and solutions surrounding cell and gene therapy.
Since the first approved gene therapy trial in 1990, interest in cell and gene therapies has increased rapidly, changing the course of research on disease prevention and treatment. However, there are still many challenges facing the field today, and further progress to be made in developing effective therapies. Attendees at the Advancing CGT Virtual Event will have the opportunity to learn more about various topics, such as developing AAV-based gene therapies, cold chain products and solutions for ....

United States , Adriana Suarez , Elizabeth Louie , Pacific Biosciences , Jude Samulski , Lionel Galibert , Brianj Hawkins , Melissa Fisher , Andrea Ohara , Michael Weiand , A Brooks Life Sciences Company , Brooks Life Sciences , Kuopio Center , Pluristyx Inc , Technology Advisor , Virtual Event , Senior Scientist , Cell Therapy , Chief Technology Officer , Technical Applications , Brooks Life Sciences Company , Andreao Hara , Technical Application Scientist , Chief Scientific Officer , Field Applications Manager , Linda De Jesus ,

Dr. Loupy, French Transplant Physician and Researcher Awarded GENEWIZ Digital Spatial Profiler Grant


Share this article
Share this article
SOUTH PLAINFIELD, N.J., Jan. 7, 2021 /PRNewswire/ Leading global genomics service provider, GENEWIZ, a Brooks Life Sciences Company, announced today that Alexandre Loupy, MD, Ph.D., Professor of Nephrology and Epidemiology at Necker Hospital, Paris, and Director of the Paris Transplant Group at Inserm, France, has been awarded the GENEWIZ Digital Spatial Profiler Grant. Dr. Loupy will be provided digital spatial profiling services on the NanoString Technologies® GeoMx™ platform for his study investigating the spatial immune response during allograft rejection.
The success or failure of organ transplantation largely depends on rejection responses. Rejection accounts for most allograft failures worldwide, with immediate effects on patient mortality, morbidity –  presenting various complications for the patient health – and high societal costs. For nearly 30 years, the Banff Classification of Allograft Pathology has provided ....

United States , France General , United Kingdom , Lindsay Kendall Zuill , Blaise Robin , Alexandre Loupy , French National Medical Research Agency , Paris Transplant Group , Paris Transplant Group At Inserm , Genomics Services , Company Life Sciences , Expertise Center , Brooks Life Sciences Company , Necker Hospital , Spatial Profiler , Nanostring Technologies , Banff Classification , Allograft Pathology , Banff Kidney Meeting , Ginger Zhou , Vice President , Life Sciences , Brooks Life Science , North America , South Plainfield , French National Medical Research ,